BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37988668)

  • 1. Multiple immunoassay interference in a patient with falsely elevated calcitonin.
    Unal MC; Bayraktar AC; Uslu T; Yener S
    Arch Endocrinol Metab; 2023 Nov; 68():e230074. PubMed ID: 37988668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Falsely elevated thyroglobulin and calcitonin due to rheumatoid factor in non-relapsing thyroid carcinoma: A case report.
    Lupoli GA; Barba L; Liotti A; La Civita E; Lupoli R; Riccio E; Portella G; Formisano P; Beguinot F; Terracciano D
    Medicine (Baltimore); 2019 Feb; 98(5):e14178. PubMed ID: 30702570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.
    Rieu M; Lame MC; Richard A; Lissak B; Sambort B; Vuong-Ngoc P; Berrod JL; Fombeur JP
    Clin Endocrinol (Oxf); 1995 May; 42(5):453-60. PubMed ID: 7621562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterophilic antibodies causing falsely high serum calcitonin values.
    Papapetrou PD; Polymeris A; Karga H; Vaiopoulos G
    J Endocrinol Invest; 2006 Nov; 29(10):919-23. PubMed ID: 17185902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays.
    Preissner CM; O'Kane DJ; Singh RJ; Morris JC; Grebe SK
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3069-74. PubMed ID: 12843145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of spurious hypercalcitoninemia: a cautionary tale on the use of plasma calcitonin assays in the screening of patients with thyroid nodules for neoplasia.
    Uwaifo GI; Remaley AT; Stene M; Reynolds JC; Yen PM; Snider RH; Becker KL; Sarlis NJ
    J Endocrinol Invest; 2001 May; 24(5):361-9. PubMed ID: 11407657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrocalcitonin Is a Novel Pitfall in the Routine of Serum Calcitonin Immunoassay.
    Alves TG; Kasamatsu TS; Yang JH; Meneghetti MC; Mendes A; Kunii IS; Lindsey SC; Camacho CP; Dias da Silva MR; Maciel RM; Vieira JG; Martins JR
    J Clin Endocrinol Metab; 2016 Feb; 101(2):653-8. PubMed ID: 26647152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Diagnosis of Medullary Thyroid Cancer: Are Calcitonin Stimulation Tests Still Indicated in the Era of Highly Sensitive Calcitonin Immunoassays?
    Niederle MB; Scheuba C; Riss P; Selberherr A; Koperek O; Niederle B
    Thyroid; 2020 Jul; 30(7):974-984. PubMed ID: 32056502
    [No Abstract]   [Full Text] [Related]  

  • 9. Detecting the interferences in adrenocorticotropic hormone measurement - three cases reinforcing the efficiency of the complementary clinical and laboratory audit.
    Barlas T; Yalcin MM; Osmanov Z; Gulbahar O; Altinova AE; Akturk M; Karakoc MA; Yetkin I; Toruner FB
    Biochem Med (Zagreb); 2024 Feb; 34(1):010802. PubMed ID: 38125613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
    Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A
    J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spurious hypercalcitoninemia in patients with nodular thyroid disease induced by heterophilic antibodies.
    Kim JM; Chung KW; Kim SW; Choi SH; Min HS; Kim JN; Won WJ; Kim SK; Lee JI; Chung JH; Kim SW
    Head Neck; 2010 Jan; 32(1):68-75. PubMed ID: 19536770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitonin measurement and immunoassay interference: a case report and literature review.
    Censi S; Cavedon E; Fernando SW; Barollo S; Bertazza L; Zambonin L; Zaninotto M; Faggian D; Plebani M; Mian C
    Clin Chem Lab Med; 2016 Dec; 54(12):1861-1870. PubMed ID: 27166721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental Study of Interference in Calcitonin Testing: A Case Report and Literature Review.
    Zhang X; Liu Y; Liu X; Shu H; Dong Z
    Endocr Metab Immune Disord Drug Targets; 2024 May; ():. PubMed ID: 38798210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitive calcitonin measurement by two-site immunometric assays: implications for calcitonin screening in nodular thyroid disease.
    Saller B; Görges R; Reinhardt W; Haupt K; Janssen OE; Mann K
    Clin Lab; 2002; 48(3-4):191-200. PubMed ID: 11934221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. False serum calcitonin high levels using a non-competitive two-site IRMA.
    Tommasi M; Brocchi A; Cappellini A; Raspanti S; Mannelli M
    J Endocrinol Invest; 2001 May; 24(5):356-60. PubMed ID: 11407656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterophile antibodies may falsely increase or decrease thyroglobulin measurement in patients with differentiated thyroid carcinoma.
    Giovanella L; Keller F; Ceriani L; Tozzoli R
    Clin Chem Lab Med; 2009; 47(8):952-4. PubMed ID: 19589101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic value of calcitonin measurement in wash-out fluid from fine-needle aspiration of thyroid nodules in the diagnosis of medullary thyroid cancer.
    Diazzi C; Madeo B; Taliani E; Zirilli L; Romano S; Granata AR; De Santis MC; Simoni M; Cioni K; Carani C; Rochira V
    Endocr Pract; 2013; 19(5):769-79. PubMed ID: 23757613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Case With Immunoassay Interferences in the Measurement of Multiple Hormones.
    Gulbahar O; Konca Degertekin C; Akturk M; Yalcin MM; Kalan I; Atikeler GF; Altinova AE; Yetkin I; Arslan M; Toruner F
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2147-53. PubMed ID: 25897621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterophilic antibody interference with TSH measurement on different immunoassay platforms.
    Cheng X; Guo X; Chai X; Hu Y; Lian X; Zhang G
    Clin Chim Acta; 2021 Jan; 512():63-65. PubMed ID: 33285118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
    Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.